[Cancer of the corpus uteri].

dometrial cancer, hormone replacement is often prescribed after menopause to reduce the risk of cardiovascular disease and osteoporosis and to relieve meno-pausal symptoms. "The outcome of this trial could help resolve a clinical dilemma facing thousands of endometrial cancer survivors and their physicians," said Robert C.